Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study

Clinical trial NCT04304105 · COMPLETED

Trial details

NCT number: NCT04304105
Sponsor: LimFlow, Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Critical Limb Ischemia Peripheral Artery Disease

Start date: 2020-02-24
Primary completion: 2022-09-12
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.